When you enter multiple keywords separated by space, your search will contain results that match any of the keywords (OR search).
  • 51 Hits
  • Search Condition : Filter (MeSH = Ovarian Neoplasms / genetics*)
Species Resource Title
Human and Animal Cells JHOC-5(RCB1520) , JHOC-9(RCB2226) MicroRNA-21 is a candidate driver gene for 17q23-25 amplification in ovarian clear cell carcinoma.
Human and Animal Cells KGN(RCB1154) Gene analysis of major signaling pathways regulated by gonadotropins in human ovarian granulosa tumor cells (KGN)†.
Human and Animal Cells JHOS-4(RCB1678) Elevated LINC00909 Promotes Tumor Progression of Ovarian Cancer via Regulating the miR-23b-3p/MRC2 Axis.
Human and Animal Cells JHOS-2(RCB1521) , JHOC-5(RCB1520) CHD4 regulates platinum sensitivity through MDR1 expression in ovarian cancer: A potential role of CHD4 inhibition as a combination therapy with platinum agents.
Human and Animal Cells OV2944-HM-1(RCB1483) Expression of Vascular Endothelial Growth Factor in Ovarian Cancer Inhibits Tumor Immunity through the Accumulation of Myeloid-Derived Suppressor Cells.
Human and Animal Cells KGN(RCB1154) Comparative study of microRNA regulation on FOXL2 between adult-type and juvenile-type granulosa cell tumours in vitro.
Human and Animal Cells JHOC-5(RCB1520) , JHOC-7(RCB1688) , JHOC-9(RCB2226) , JHOM-1(RCB1676) , JHOS-3(RCB1546) Enhanced GAB2 Expression Is Associated with Improved Survival in High-Grade Serous Ovarian Cancer and Sensitivity to PI3K Inhibition.
Human and Animal Cells HHUA(RCB0658) Novel target genes responsive to the anti-growth activity of triptolide in endometrial and ovarian cancer cells.
Human and Animal Cells OVK18(RCB1903) GEP oncogene promotes cell proliferation through YAP activation in ovarian cancer.
Human and Animal Cells JHOS-2(RCB1521) , JHOS-3(RCB1546) , JHOS-4(RCB1678) Epigenetic Modifier SETD8 as a Therapeutic Target for High-Grade Serous Ovarian Cancer.
Human and Animal Cells JHOC-5(RCB1520) , JHOC-9(RCB2226) High Expression of p21 as a Potential Therapeutic Target in Ovarian Clear-cell Carcinoma.
Human and Animal Cells JHOC-5(RCB1520) , JHOC-7(RCB1688) , JHOC-8(RCB1723) , JHOC-9(RCB2226) Met is the most frequently amplified gene in endometriosis-associated ovarian clear cell adenocarcinoma and correlates with worsened prognosis.
Human and Animal Cells JHOC-7(RCB1688) , JHOC-9(RCB2226) MDM2 is a potential therapeutic target and prognostic factor for ovarian clear cell carcinomas with wild type TP53.
Human and Animal Cells OVK18(RCB1903) Oncogenic and drug-sensitive RET mutations in human epithelial ovarian cancer.
Human and Animal Cells OVK18(RCB1903) Upregulation of cyclase-associated actin cytoskeleton regulatory protein 2 in epithelial ovarian cancer correlates with aggressive histologic types and worse outcomes.
Human and Animal Cells FM3A(RCB0086) , KLN205(RCB2623) , Ehrlich(RCB0142) , Colon-26(RCB2657) , OV2944-HM-1(RCB1483) , Hepa 1-6(RCB1638) , MBT-2(RCB0544) Comprehensive Analysis of Mouse Cancer/Testis Antigen Functions in Cancer Cells and Roles of TEKT5 in Cancer Cells and Testicular Germ Cells.
Human and Animal Cells KGN(RCB1154) The four and a half LIM domains 2 (FHL2) regulates ovarian granulosa cell tumor progression via controlling AKT1 transcription.
Human and Animal Cells JHOC-5(RCB1520) PIK3CA hotspot mutations and cyclooxygenase-2 expression in ovarian clear cell carcinomas: a close association with stromal features.
Human and Animal Cells JHUEM-2(RCB1551) , JHUEM-7(RCB1677) VISTA expressed in tumour cells regulates T cell function.
Human and Animal Cells KGN(RCB1154) KMT2D/MLL2 inactivation is associated with recurrence in adult-type granulosa cell tumors of the ovary.